{"log_id": 603014241435464911, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 1e-06, "average": 0.998711, "min": 0.997083}, "location": {"width": 222, "top": 126, "height": 35, "left": 200}, "words": "将来可获得的其它资料"}, {"probability": {"variance": 2e-06, "average": 0.999144, "min": 0.994527}, "location": {"width": 860, "top": 156, "height": 55, "left": 200}, "words": "在现在的科学水平下,更全面的资料尚未提供。销售授权拥有者正在做一项前瞻性研究,在"}, {"probability": {"variance": 0.000208, "average": 0.996557, "min": 0.908373}, "location": {"width": 850, "top": 188, "height": 54, "left": 199}, "words": "由应用去铁胺转化为应用去铁酮治疗的患者中,评估其对淋巴细胞染色体断裂的影响。另外"}, {"probability": {"variance": 0, "average": 0.999354, "min": 0.999071}, "location": {"width": 29, "top": 113, "height": 123, "left": 1185}, "words": "品骑"}, {"probability": {"variance": 3e-06, "average": 0.998702, "min": 0.993168}, "location": {"width": 783, "top": 220, "height": 52, "left": 197}, "words": "近100名地中海贫血患者服用去铁酮4年的安全有效性追踪报告资料将会尽快提供"}, {"probability": {"variance": 6e-06, "average": 0.998326, "min": 0.99222}, "location": {"width": 243, "top": 286, "height": 32, "left": 195}, "words": "[孕妇及哺乳期妇女用药]"}, {"probability": {"variance": 4e-06, "average": 0.998436, "min": 0.988988}, "location": {"width": 861, "top": 316, "height": 58, "left": 194}, "words": "在非铁负荷的大鼠和兔子进行的生殖毒性研究显示,25mg/kg的去铁酮具有胚胎毒性、致畸"}, {"probability": {"variance": 0, "average": 0.999471, "min": 0.998985}, "location": {"width": 48, "top": 353, "height": 24, "left": 194}, "words": "毒性"}, {"probability": {"variance": 2e-06, "average": 0.999209, "min": 0.993743}, "location": {"width": 861, "top": 415, "height": 55, "left": 191}, "words": "尚无关于怀孕妇女的资料,但是基于动物试验结果,怀孕和哺乳期妇女禁用去铁酮。由于药"}, {"probability": {"variance": 2e-06, "average": 0.999109, "min": 0.994189}, "location": {"width": 860, "top": 448, "height": 55, "left": 190}, "words": "物的致突变性和致染色体断裂,育龄妇女应避免怀孕,这些妇女应采取避孕措施,如果怀孕"}, {"probability": {"variance": 4e-06, "average": 0.998796, "min": 0.99178}, "location": {"width": 352, "top": 482, "height": 38, "left": 190}, "words": "或计划怀孕,应立即停止服用去铁酮"}, {"probability": {"variance": 1.8e-05, "average": 0.996984, "min": 0.988483}, "location": {"width": 103, "top": 548, "height": 28, "left": 186}, "words": "[儿童用药"}, {"probability": {"variance": 1.2e-05, "average": 0.998563, "min": 0.980645}, "location": {"width": 639, "top": 578, "height": 50, "left": 186}, "words": "610岁儿童服用去铁酮的资料有限,尚无6岁以下儿童服用的资料"}, {"probability": {"variance": 2.4e-05, "average": 0.995142, "min": 0.988095}, "location": {"width": 114, "top": 645, "height": 28, "left": 183}, "words": "[老年用药]"}, {"probability": {"variance": 2e-06, "average": 0.998865, "min": 0.995281}, "location": {"width": 330, "top": 677, "height": 37, "left": 184}, "words": "未进行该项实验且无可靠参考文献"}, {"probability": {"variance": 1e-06, "average": 0.999199, "min": 0.996981}, "location": {"width": 149, "top": 744, "height": 27, "left": 181}, "words": "[药物相互作用"}, {"probability": {"variance": 1e-06, "average": 0.999225, "min": 0.995774}, "location": {"width": 735, "top": 774, "height": 50, "left": 181}, "words": "尚无去铁酮和其他药物相互作用的报告。但是由于该化合物与金属阳离子结合"}, {"probability": {"variance": 2.1e-05, "average": 0.998051, "min": 0.973611}, "location": {"width": 861, "top": 804, "height": 58, "left": 181}, "words": "与含三价阳离子的药物,例如含铝离子的抗酸剂,会存在潜在的药物相互作用。尚无去铁酮"}, {"probability": {"variance": 0.007644, "average": 0.973215, "min": 0.552395}, "location": {"width": 863, "top": 838, "height": 54, "left": 179}, "words": "与维生素C同服的安全性的正式研究。基于同服去铁酮和维生素C出现不良的相互作用的报"}, {"probability": {"variance": 7.1e-05, "average": 0.996563, "min": 0.956597}, "location": {"width": 862, "top": 870, "height": 55, "left": 177}, "words": "告,当同服这两种药物时应慎重。由于尚不清楚去铁酮诱导中性粒细胞减少的机制,所以患"}, {"probability": {"variance": 5e-06, "average": 0.998697, "min": 0.990956}, "location": {"width": 656, "top": 903, "height": 46, "left": 176}, "words": "者不可服用已知与中性粒细胞减少症有关或可引起粒细胞缺乏的药物"}, {"probability": {"variance": 5e-06, "average": 0.998237, "min": 0.993672}, "location": {"width": 105, "top": 969, "height": 26, "left": 173}, "words": "[药物过量"}, {"probability": {"variance": 5.4e-05, "average": 0.996474, "min": 0.966283}, "location": {"width": 862, "top": 997, "height": 58, "left": 174}, "words": "尚无服用去铁酮急性过量的报告。然而,对于多年按医嘱服用超过最大推荐剂量(100mgkg"}, {"probability": {"variance": 5.5e-05, "average": 0.996374, "min": 0.963372}, "location": {"width": 863, "top": 1031, "height": 55, "left": 173}, "words": "日)2.5倍的儿童,已发现有神经系统病变发生(如大脑症状,复视、侧向眼球震颤、精神"}, {"probability": {"variance": 1e-06, "average": 0.999169, "min": 0.994617}, "location": {"width": 816, "top": 1065, "height": 52, "left": 172}, "words": "运动减慢、手部运动及轴向肌张力减低)。在停用去铁酮后,神经系统病变可逐渐消退"}, {"probability": {"variance": 1.6e-05, "average": 0.996821, "min": 0.989124}, "location": {"width": 111, "top": 1131, "height": 26, "left": 170}, "words": "[药理毒理]"}, {"probability": {"variance": 1e-06, "average": 0.998991, "min": 0.997114}, "location": {"width": 91, "top": 1165, "height": 25, "left": 168}, "words": "药理作用"}, {"probability": {"variance": 0.002282, "average": 0.984664, "min": 0.700067}, "location": {"width": 862, "top": 1194, "height": 55, "left": 168}, "words": "去铁酮片(奥贝安可)其活性成分为去铁酮(3-羟基-1,2-二甲基-4-(1H)-吡啶酮),是一个与"}, {"probability": {"variance": 8e-06, "average": 0.998569, "min": 0.98336}, "location": {"width": 863, "top": 1228, "height": 55, "left": 166}, "words": "铁以3:1摩尔比键合的二齿配位体。临床试验证实去铁酮可有效促进铁排除,阻止输血依"}, {"probability": {"variance": 0.000394, "average": 0.995754, "min": 0.871998}, "location": {"width": 861, "top": 1260, "height": 56, "left": 165}, "words": "赖的地中海贫血患者血清铁负荷的蓄积。在2个Ⅲ期临床试验和1个和地中海贫血关怀项目"}, {"probability": {"variance": 0.000324, "average": 0.994408, "min": 0.890221}, "location": {"width": 865, "top": 1295, "height": 54, "left": 162}, "words": "共247名患者的研究中,血清铁蛋白浓度被作为主要的疗效评估标准。一个与去铁胺相对照"}, {"probability": {"variance": 1e-06, "average": 0.999397, "min": 0.997462}, "location": {"width": 864, "top": 1329, "height": 54, "left": 163}, "words": "的历时2年的去铁酮治疗研究,2个治疗组的平均血清铁蛋白浓度无显著性差异。其他研究"}, {"probability": {"variance": 1.3e-05, "average": 0.998242, "min": 0.980363}, "location": {"width": 850, "top": 1361, "height": 55, "left": 164}, "words": "为支持性、开放性、非对照研究。在研究中,患者的血清铁蛋白浓度保持在了治疗前的水平"}, {"probability": {"variance": 6e-06, "average": 0.997377, "min": 0.994339}, "location": {"width": 91, "top": 1431, "height": 25, "left": 161}, "words": "毒理作用"}, {"probability": {"variance": 0.000891, "average": 0.993911, "min": 0.807932}, "location": {"width": 861, "top": 1460, "height": 54, "left": 161}, "words": "已在动物包括小鼠、大鼠、兔子、狗和猴子进行了本品的临床前安全性研究,本品的主要毒"}, {"probability": {"variance": 1e-06, "average": 0.999311, "min": 0.992812}, "location": {"width": 864, "top": 1491, "height": 57, "left": 157}, "words": "性为骨髓抑制和相关的白细胞计数降低。在非铁负荷增高的动物中,上述症状出现在"}, {"probability": {"variance": 0.004952, "average": 0.980631, "min": 0.543594}, "location": {"width": 848, "top": 1524, "height": 57, "left": 161}, "words": "100mg/kg/日及其以上剂量,并呈剂量依赖关系。在上述动物,毒性和组织铁负荷呈负相关"}], "language": 3}